作为糖尿病治疗点的Sirtuins
Kajetan Kielbowski1, Aleksandra Wiktoria Bratborska2, Estera Bakinowska1
1Department of Physiology, Pomeranian Medical University, Szczecin, Poland.
赛尔图因 (SIRT) 是代谢和炎症途径中的关键酶. 研究探讨了它们在糖尿病,肥胖和相关并发症中的作用,并有可能开发有针对性的药物.
科学领域:
- 生物化学 生物化学
- 代谢研究的研究.
- 蜂信号传输是如何进行的
背景情况:
- 赛尔图因 (SIRT) 是NAD+依赖的脱乙酶,参与蛋白质的翻译后修饰.
- 哺乳动物SIRT与关键的代谢和炎症途径相互作用.
- 研究SIRT在代谢和炎症疾病中的作用.
研究的目的:
- 审查SIRT在胰腺β细胞功能,葡萄糖代谢,胰岛素分泌和脂质代谢中的参与.
- 总结关于糖尿病,肥胖和糖尿病并发症中SIRT调节的证据.
- 突出SIRT向治疗开发的挑战和未来方向.
主要方法:
- 关于sirtuins和代谢疾病的研究的综合文献综述.
- 对SIRT表达和活动调节的现有证据的分析.
- 讨论SIRT分子建模和药物开发策略.
主要成果:
- 在胰腺β细胞功能障碍,葡萄糖耐受性,胰岛素分泌,脂质代谢和脂肪细胞功能中,SIRT起着重要作用.
- 有证据表明,SIRT表达和活动与糖尿病,肥胖及其并发症有关.
- 开发选择性SIRT激活剂/抑制剂是具有挑战性但有前途的.
结论:
- SIRT是代谢过程和炎症反应的关键调节者.
- 向SIRT为代谢性疾病提供了潜在的治疗策略.
- 需要进一步的研究和临床试验才能充分实现SIRT的治疗潜力.
更多相关视频
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Biguanides and Glitazones
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Oral Hypoglycemic Agents: Sulfonylureas
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
